Related Experiment Video
Updated: Jul 17, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Risk stratification of outcomes after coronary artery bypass grafting in ischemic cardiomyopathy with symptomatic
Shin Yajima1, Kazutaka Nishio2, Akinobu Ohtani3
1Department of Cardiovascular Surgery, The University of Osaka Graduate School of Medicine, 2‑2 Yamadaoka, Suita, 565‑0871, Osaka, Japan. s-yajima@surg1.med.osaka-u.ac.jp.
Insights
Older age, high creatinine, and prior percutaneous coronary intervention predict worse outcomes in ischemic cardiomyopathy patients after coronary artery bypass grafting. Total revascularization improves survival.
Area of Science:
- Cardiology
- Cardiac Surgery
- Regenerative Medicine
Background:
- Investigating predictors of mortality and heart failure events in patients with symptomatic ischemic cardiomyopathy (ICM).
- Identifying stratification variables for future regenerative therapy trials in ICM patients undergoing coronary artery bypass grafting (CABG).
Purpose of the Study:
- To identify predictors of all-cause mortality and heart failure (HF) events in patients with ICM undergoing isolated CABG.
- To explore potential stratification variables for future regenerative therapy trials.
Main Methods:
- Retrospective analysis of 90 patients with ICM, ejection fraction ≤40%, and NYHA class ≥II undergoing primary isolated CABG.
- Assessment of clinical characteristics, operative data, and long-term outcomes (all-cause mortality, HF events).
- Prognostic factor evaluation using Kaplan-Meier analyses and multivariate Cox proportional hazard models.
Main Results:
- Median follow-up of 45 months revealed 30.0% mortality, 15.6% HF readmissions, and 42.2% HF events.
- Older age and high creatinine levels independently predicted mortality and HF events.
- Prior percutaneous coronary intervention was linked to mortality; total revascularization showed a protective effect.
Conclusions:
- Older age, elevated creatinine, and prior PCI are associated with poorer survival in symptomatic ICM patients post-CABG.
- Total revascularization is linked to improved survival outcomes.
- Findings suggest potential stratification variables for future regenerative therapy studies.
Background:
To identify the predictors of all-cause mortality and heart failure (HF) events in patients with ischemic cardiomyopathy (ICM) undergoing isolated coronary artery bypass (CABG) grafting who present with symptomatic HF, and to identify potential stratification variables for future regenerative therapy trials.
Methods:
We retrospectively analyzed data from 90 patients with ICM, left ventricular ejection fraction of ≤ 40%, and New York Heart Association class ≥ II who underwent primary isolated CABG. Clinical characteristics, operative data, and long-term outcomes were assessed. The primary endpoints were all-cause mortality and incidence of HF events, defined as a composite of all-cause mortality and initial HF readmission. Prognostic factors were evaluated using Kaplan-Meier analyses and multivariate Cox proportional hazard models.
Results:
During the median follow-up period of 45 months, 27 (30.0%) deaths, 14 (15.6%) HF readmissions, and 38 (42.2%) HF events occurred. Multivariate analysis identified older age (hazard ratio [HR], 1.09; 95% confidence interval [CI], 1.02-1.17) and high creatinine levels (HR, 1.62; 95% CI, 1.23-2.13) as independent predictors of all-cause mortality and HF events. A history of percutaneous coronary intervention was independently associated with all-cause mortality (HR, 2.60; 95% CI, 1.09-6.22). Total revascularization was independently protective against all-cause mortality (HR, 0.21; 95% CI, 0.06-0.74).
Conclusions:
Among symptomatic patients with ICM undergoing CABG, older age, high creatinine levels, and a history of percutaneous coronary intervention were associated with worse survival outcomes, whereas total revascularization was associated with improved survival. These findings should be interpreted as exploratory and may help identify potential stratification variables for future prospective studies of adjunctive regenerative therapy.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure I: Introduction
